CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: TKID was generated with the same Affymetrix chips as CMLD1 and CMLD2 and contained the gene expression data of the treatment naïve chronic phase CML samples at baseline (CD34+CD38− cells) and after 7 days in vitro TKI treatment (7 d, CD34+ cells).